Navigation Links
InterMune Reports Fourth Quarter and Full Year 2008 Financial Results and Business Highlights
Date:2/26/2009

BRISBANE, Calif., Feb. 26 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN) today announced results from operations for the fourth quarter and 12 months ended December 31, 2008. InterMune reported a net loss for the fourth quarter of 2008 of $32.3 million, or $0.83 per share, compared with a net loss of $25.9 million, or $0.67 per share, in the fourth quarter of 2007.

Dan Welch, Chairman, Chief Executive Officer and President of InterMune said, "Fourth quarter and recent events have highlighted our very significant progress on pirfenidone and ITMN-191 (R7227). We recently reported results of our Phase 3 CAPACITY program for pirfenidone in idiopathic pulmonary fibrosis (IPF) and are now preparing the New Drug Application (NDA) and Marketing Authorization Application (MAA) for the United States and European Union, respectively. We also reported very positive top-line results of our triple combination study of ITMN-191 with Pegasys(R) (pegylated interferon alfa-2a) and Copegus(R) (ribavirin) and launched the innovative all-oral treatment study, INFORM-1, in patients chronically infected with the hepatitis C virus (HCV)."

Results for Fourth Quarter 2008

InterMune reported total revenue in the fourth quarter of 2008 of $7.4 million, compared with total revenue of $9.6 million in the fourth quarter of 2007. Total revenue in the fourth quarter of 2008 primarily consisted of Actimmune(R) (interferon gamma-1b) revenue of $6.6 million, compared with $8.8 million in the fourth quarter of 2007, a decrease of 25%, reflecting lower off-label physician prescriptions of Actimmune for the treatment of IPF, which InterMune does not promote. Fourth quarter total revenue also included revenue from the collaboration with Roche for the development of protease inhibitors, including ITMN-191, which totaled
'/>"/>

SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. InterMune to Release Fourth Quarter, Full Year 2008 Financial Results on February 26
2. InterMune Announces Issuance of U.S. Patent for ITMN-191
3. InterMune Announces Pricing of Public Offering of 3,500,000 Shares of Common Stock
4. InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF
5. InterMune to Present at J.P. Morgan Healthcare Conference
6. InterMune to Present at Deutsche Bank Biotech Boston Confab
7. InterMune Reports Third Quarter 2008 Financial Results and Business Highlights
8. InterMune to Release Third Quarter 2008 Financial Results on November 6
9. InterMune Reports Japanese Regulatory Approval of Pirfenidone in IPF
10. InterMune to Present Four Abstracts on HCV Protease Inhibitor ITMN-191 at the AASLD Meeting
11. InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... Two new members were elected to ... its annual Shareholders Meeting on June 13: Kerry R. ... PFM Group, and Stephen T. Zarrilli, President and CEO ... election of Michael A. DiPiano, Managing General Partner of ... P. Jaffe, Esq., of Duane Morris LLP, as Director ...
(Date:7/22/2014)... en SHENZHEN, China , 22 ... (BGI Tech), een dochtermaatschappij van BGI, ,s wereld grootste ... introductie aan van een nieuwe service ten behoeve van ... geavanceerde platform van Complete Genomics. In ... de sector in hoog aanzien staat vanwege de in ...
(Date:7/22/2014)... Mass. , July 22, 2014  The ... $650 million from philanthropist Ted Stanley ... and bringing new treatments based on molecular understanding ... world. The Stanley commitment – ... the largest for scientific research in general – ...
(Date:7/22/2014)... KS (PRWEB) July 22, 2014 ... attention-deficit hyperactivity disorder (ADHD) is diagnosed, selecting medication to ... and error. Analyzing brain patterns by using electroencephalography (EEG) ... result and thus lower the risk of adverse drug ... Phenotypes and Biomarkers” in the current issue of ...
Breaking Biology Technology:Two New Members Elected to University City Science Center Board of Directors 2Two New Members Elected to University City Science Center Board of Directors 3BGI Tech introduceert service op gebied van hele menselijke exoomsequencing op geavanceerd Complete Genomics-platform 2$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 2$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 3$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 4$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 5$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 6$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 7$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 8$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 9$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 10Analyzing Brain Patterns with EEG Can Help Predict Effective Use of Medication 2Analyzing Brain Patterns with EEG Can Help Predict Effective Use of Medication 3
... (1/25/11) -- Researchers from Boston College, MIT, Clemson and ... increase in the thermoelectric figure of merit of p-type ... in the American Chemical Society journal Nano Letters ... merit, used to measure a material,s relative thermoelectric performance, ...
... Inc. (Nasdaq: CEPH ) today announced positive ... (armodafinil) Tablets [C-IV] in patients experiencing excessive sleepiness associated ... their night shifts (i.e., 4:00 a.m. to 8:00 a.m.), ... significant difference in improvement in overall clinical condition related ...
... 2011 RxTrials, Inc., a network of premier clinical ... leading national clinical research consultant and education provider, has ... WBE certification was presented by the Women,s Business Enterprise ... site visit. The nationally recognized certification from ...
Cached Biology Technology:Nanotech milling produces dramatic increase in thermoelectric performance of bulk semiconductor 2Cephalon Announces Positive Topline Results From a Phase IV Study of NUVIGIL in Shift Work Disorder 2Cephalon Announces Positive Topline Results From a Phase IV Study of NUVIGIL in Shift Work Disorder 3Cephalon Announces Positive Topline Results From a Phase IV Study of NUVIGIL in Shift Work Disorder 4RxTrials Earns National Women-Owned Business Certification 2
(Date:7/22/2014)... July 22, 2014 NXT-ID, Inc., (NXTD: OTCQB) a ... market, announces its next generation smart wallet, Wocket™, will be ... television show that airs on the History Channel, ... NewsWatch regularly features top technology products and services. ... the History Channel (6:00-6:30am ET/PT) and the FYI ...
(Date:7/21/2014)... July 21, 2014 (Toronto) As part of a ... and Mental Health (CAMH) have helped identify over 100 ... of developing schizophrenia, in what is the largest genomic ... findings, published online in Nature , point to ... could lead to new approaches to treating the disorder, ...
(Date:7/21/2014)... LSU,s Mark Batzer, Boyd Professor and Dr. Mary Lou ... the College of Science, contributed to an article in ... Common Marmoset Genome Provides Insight into Primate Biology and ... analysis of "jumping genes," or mobile elements that move ... the genome. The marmoset is important because it is ...
Breaking Biology News(10 mins):NXT-ID's Next Generation Wocket Smart Wallet to be Featured on NewsWatch, Airing on History Channel, FYI Network and ION Network 2NXT-ID's Next Generation Wocket Smart Wallet to be Featured on NewsWatch, Airing on History Channel, FYI Network and ION Network 3International team sheds new light on biology underlying schizophrenia 2International team sheds new light on biology underlying schizophrenia 3LSU's Mark Batzer contributes to Nature Genetics article on marmoset genome 2
... possible cause of a common but mysterious disease that kills ... thanks to research led by scientists at the University of ... Larry. The virus, previously not thought to infect snakes ... bane of zoo officials and exotic pet owners, the deadly ...
... journal Molecular Psychiatry , both receiving advance online ... the risks of developing obsessive-compulsive disorder (OCD) or Tourette ... Massachusetts General Hospital (MGH) investigators, and both are the ... of individuals affected by the conditions. ...
... A mysterious condition called Inclusion Body Disease (IBD) strikes ... and eventually death. Scientists investigating an outbreak of IBD ... Francisco report they may well have found a virus ... a discovery that could eventually lead to prevention and ...
Cached Biology News:Mysterious snake disease decoded 2Mysterious snake disease decoded 3Mysterious snake disease decoded 4Mysterious snake disease decoded 5First GWAS studies of obsessive-compulsive disorder and Tourette syndrome published 2First GWAS studies of obsessive-compulsive disorder and Tourette syndrome published 3Scientists discover new type of virus responsible for a devastating disease in snakes 2
Ps-Aeruginosa (IgG) -Ab EIA Sample Size: 100 l...
Ps-Aeruginosa (IgA) -Ab EIA Sample Size: 100 l...
Request Info...
... bench time to just 15 minutes! The ... that can be drawn between this exciting new ... instant foods. Instant meals consumed by astronauts, ... and are reconstituted by adding water. The ...
Biology Products: